Pharma channel feed

No speedy nasal roll­out for Ox­ford/As­traZeneca’s Covid-19 jab af­ter PhI flop

3 years ago
R&D
Coronavirus

At­trac­tive M&A op­tions? An­a­lysts break down what's hot right now

3 years ago
Deals

Up­dat­ed: In­di­an man­u­fac­tur­er un­der scruti­ny af­ter cough syrups linked to deaths in West Africa

3 years ago
Manufacturing

Are in­cen­tives nec­es­sary to achieve tri­al di­ver­si­ty? Two re­searchers say yes

3 years ago

As­traZeneca links cli­mate change and hu­man health in new cor­po­rate 'Science Can' cam­paign

3 years ago
Marketing

CDER strikes back at Van­da, dis­clos­es ra­tio­nale be­hind 2019 sN­DA re­jec­tion

3 years ago
FDA+

Sen­ate Re­pub­li­cans seek to re­peal new gov­ern­ment drug price ne­go­ti­a­tions

3 years ago
FDA+

J&J hud­dles up with for­mer NFL play­er and sur­vivor Shan­non Sharpe for prostate can­cer push

3 years ago
Marketing

Eu­ro­pean Com­mis­sion ac­cus­es Te­va of an­ti­com­pet­i­tive scheme as Co­pax­one sales sink

3 years ago

CSL Se­qirus snaps up $30M+ BAR­DA con­tract to de­vel­op in­fluen­za vac­cine at its ex­pand­ed fa­cil­i­ty in NC

3 years ago
Manufacturing

Servi­er adds a 's­mile' to its brand while set­ting am­bi­tious on­col­o­gy goals

3 years ago
Marketing

No­var­tis shoots 'From the Heart' in new video se­ries to spur dis­cus­sions — and changes — in car­dio­vas­cu­lar dis­ease

3 years ago
Marketing

'False hopes': FDA re­leas­es brief­ing docs on con­tro­ver­sial preterm birth med Mak­e­na ahead of ad­comm

3 years ago
FDA+

Al­ny­lam touts la­bel ex­pan­sion for rare ox­alate dis­ease

3 years ago

Fred Hutch re­brands af­ter merg­er, blend­ing can­cer re­search and pa­tient care lega­cies in new iden­ti­ty

3 years ago
Marketing

Ad­vo­cates pe­ti­tion FDA to make abor­tion pill ac­ces­si­ble to mis­car­riage pa­tients

3 years ago
FDA+

An AI, err ma­chine learn­ing, shop lines up Eli Lil­ly as part­ner ahead of first in-house clin­i­cal tri­al

3 years ago
Deals
AI

Eli Lil­ly hits the gas on tirzepatide in obe­si­ty, nabs rolling sub­mis­sion for po­ten­tial block­buster in­di­ca­tion

3 years ago
Marketing

R&D ac­cel­er­a­tion: Am­gen opens its sec­ond largest re­search site, with lab and of­fice space for 650 staff

3 years ago
R&D

Ad­vo­ca­cy group and for­mer an­titrust of­fi­cial look to com­ment on Il­lu­mi­na's con­tro­ver­sial Grail merg­er

3 years ago
Deals
Law

Three phar­ma lead­ers land on For­tune’s 2022 most pow­er­ful women in busi­ness list

3 years ago
Marketing

Mer­ck­'s $500M bet on Sin­ga­pore leads to new man­u­fac­tur­ing sites mak­ing Keytru­da, Gar­dasil and fu­ture in­halers

3 years ago
Manufacturing

Eli Lil­ly and Te­va pre­pare for court bat­tle over mi­graine med ri­val­ry

3 years ago
Law

Pfiz­er, BioN­Tech part­ner with Mar­vel for Avengers and Covid-fight­ing com­ic book

3 years ago
Marketing
First page Previous page 168169170171172173174 Next page Last page
A service from the Financial Times